Julia Community 🟣

Cover image for Peptidomimetic Drug Screening Service for Neurological Diseases
johnswift
johnswift

Posted on

Peptidomimetic Drug Screening Service for Neurological Diseases

Overview of Neurological Diseases
Structural, biochemical, or electrical abnormalities of the brain, spinal cord, or other nerves can lead to a range of neurological symptoms, including paralysis, muscle weakness, poor coordination, sensory loss, seizures, psychosis, pain, and altered levels of consciousness. At present, more than 600 neurological diseases have been found in the world. Neurological diseases and their sequelae affect as many as 1 billion people in the world.

Advantages of Peptidomimetic Drugs
The specific causes of nervous system problems vary, but may be due to genetics, congenital anomalies, infections, etc. Because the pathogenesis is ambiguous, it is difficult to truly treat effectively, and the medical community is working to find new drugs for the treatment of nervous system diseases. Peptide-mimetic drugs of biologically active proteins have attracted widespread attention due to their good efficacy, low molecular weight, low side effects, and better membrane penetration.

Top comments (0)